Fundamental dimension Equity attribute | BSPMLeader $0.00010.00% Cap $264P/E -0.0x QuantScore54/100 | BIOCQPeer $0.00030.00% Cap $788P/E -0.0x QuantScore52/100 | CLVRPeer $0.01120.00% Cap $19.65KP/E -0.0x QuantScore51/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
83/100 |
94/100 |
84/100 |
Valuation Multiples, PEG & DCF upside | 67/100 | 50/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 33/100 | 44/100 | 42/100 |
Growth Revenue / earnings growth & margins | 34/100 | 20/100 | 61/100 |
Sentiment Analyst ratings, targets & revisions | — | — | 33/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.0x | -0.0x | -0.0x |
Forward P/E (next FY) | — | -0.0x | -0.0x |
EV / EBITDA (TTM) | -1.3x | 0.0x | 0.3x |
Price / Sales | 0.0x | 0.0x | 0.0x |
Price / Free Cash Flow | 0.0x | -0.0x | -0.0x |
PEG ratio | -0.00 | 0.00 | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | — | 3 / 9 |
Altman Z-Score | 0.02 (Distress) | — | -10.11 (Distress) |
Total debt / equity | 0.06 | 1.37 | 0.09 |
Quick ratio | 1.3x | 2.8x | 1.6x |
Interest coverage | -17.3x | -101.2x | -339.0x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -91.2% | -57.8% | +6.1% |
Net income growth YoY | +77.3% | -1036.2% | +72.9% |
Gross margin (TTM) | 38.4% | -10.0% | 37.6% |
Operating margin (FY) | -149.5% | -123.7% | -89.5% |
FCF margin (FY) | 206.1% | -54.5% | -66.3% |
5. Trailing price performancePrice change over period |
1M return | +0.0% | +50.0% | +11100.0% |
3M return | +0.0% | +200.0% | +11100.0% |
6M return | +0.0% | +200.0% | +1766.7% |
Year to date | +0.0% | +200.0% | +5500.0% |
1Y return | +0.0% | +200.0% | +11100.0% |
3Y return | 0.0% | -99.9% | -99.5% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $0.1372 +137133.3% upside | $-7,141.70 -2380567319.0% premium | $-423.31 -3779670.7% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | 50% Buy50% Hold0% Sell |